-
IR
2024/11/06
Notice Regarding Extension of Trust Term and an Additional Financial Contribution to the ESOP Trust
-
IR
2024/11/06
Consolidated Financial Result Digest FY2025/3 2Q (Fiscal Year Ended March 31, 2025)
-
IR
2024/11/06
Notice of Revised Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025
-
IR
2024/11/06
Consolidated Financial Results for the Six Months of the Fiscal Year Ended March 31, 2025
-
IR
2024/09/17
Notice Regarding Personnel Changes
-
IR
2024/09/17
Notice Regarding an Additional Financial Contribution to the ESOP Trust
-
IR
2024/09/05
Annual Securities Report For the 78th business term (April 1, 2023 to March 31, 2024)
-
IR
2024/08/01
Consolidated Financial Result Digest FY2025/3 Q1 (Fiscal Year Ended March 31, 2025)
-
IR
2024/08/01
Notice of Revised the First-half and Full-year Earnings Forecasts for the Fiscal Year Ended March 31, 2025
-
IR
2024/08/01
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025
-
IR
2024/07/09
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
-
IR
2024/06/27
[Delayed]Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
-
IR
2024/06/20
Notice Regarding Personnel Changes
-
IR
2024/06/17
Matters Concerning Controlling Shareholders, Etc.
-
IR
2024/06/17
Notice Regarding Personnel Changes
-
IR
2024/06/17
Notice Regarding Chairman of the Board of Directors
-
IR
2024/06/17
Notice Regarding Responsibilities of Board Directors
-
IR
2024/06/15
Notice of resolutions at 78th Ordinary General Shareholders’ Meeting
-
IR
2024/06/14
Notice Regarding Launch of “MADOPAR® Combination Tablets L50” for a Treatment of Parkinsonism
-
IR
2024/06/13
[Delayed]Notice Regarding Partial Amendment of the Articles of Incorporation
-
IR
2024/06/13
[Delayed]Notice Regarding Company’s Propositions For 78th Ordinary General Shareholders’ Meeting
-
IR
2024/05/23
NOTICE OF 78TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
-
IR
2024/05/13
Notice Regarding Introduction of Post Issuance-Type Restricted Stock Granting Plan for Executive Officers, Etc.
-
IR
2024/05/13
Notice Regarding the Change of the Candidates for Board Directors
-
IR
2024/05/01
Notice Regarding Personnel Changes
-
IR
2024/05/01
Consolidated Financial Result Digest FY2024/3 Q4 (Fiscal Year Ended March 31, 2024)
-
IR
2024/05/01
Notice Regarding Recognition of Extraordinary Losses
-
IR
2024/05/01
Notice regarding dividends from surplus
-
IR
2024/05/01
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
-
IR
2024/04/10
Notice Regarding Change of Major Shareholder
-
IR
2024/04/01
Notice regarding acquisition and acquisition completion of Treasury Stock
-
IR
2024/03/21
Integrated Report 2023
-
IR
2024/03/15
Notice of the Candidates for Board Directors
-
IR
2024/03/15
Notice Regarding Personnel Changes
-
IR
2024/03/08
Notice regarding acquisition of treasury stock
-
IR
2024/02/15
Notice Regarding Receiving Manufacturing and Marketing Approval for Additional Formulation, Madopar® L50 Combination Tablets for the Treatment of Parkinsonism
-
IR
2024/02/09
Notice regarding acquisition of treasury stock
-
IR
2024/02/02
Consolidated Financial Result Digest FY2024/3 Q3 (Fiscal Year Ended March 31, 2024)
-
IR
2024/02/02
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2024
-
IR
2024/01/31
Notice Regarding Green Loan Agreement
-
IR
2024/01/10
Notice regarding acquisition of treasury stock
-
IR
2022/11/16
Notice regarding acquisition and acquisition completion of Treasury Stock
-
IR
2022/11/10
Notice regarding acquisition of Treasury Stock
-
IR
2022/11/07
Notice Regarding Disclosure of Information Based on TCFD Recommendations
-
IR
2022/11/07
Consolidated Financial Result Digest FY2023/3 2Q (Fiscal Year Ending March 31, 2023)
-
IR
2022/11/07
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2023
-
IR
2022/10/07
Notice regarding acquisition of Treasury Stock
-
IR
2022/09/16
Notice regarding organizational changes and personnel changes
-
IR
2022/09/09
Annual Securities Report for the 76th business term (April 1, 2021, to March 31, 2022)
-
IR
2022/09/09
Notice regarding acquisition of Treasury Stock
-
IR
2022/08/22
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
-
IR
2022/08/10
Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System
-
IR
2022/08/10
Notice regarding acquisition of Treasury Stock
-
IR
2022/08/05
Notice Regarding Responses to Questions Received Upon Application to View Internet Stream
-
IR
2022/07/27
Notice regarding personnel changes
-
IR
2022/07/27
Consolidated Financial Result Digest FY2023/3 1Q (Fiscal Year Ending March 31, 2023)
-
IR
2022/07/27
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2023
-
IR
2022/07/08
Notice regarding acquisition of Treasury Stock
-
IR
2022/06/20
Matters Concerning Controlling Shareholders, Etc.
-
IR
2022/06/20
Notice regarding personnel changes
-
IR
2022/06/20
Notice regarding Chairman of the Board of Directors
-
IR
2022/06/20
Notice regarding changes in representative directors (Additional Appointment) and responsibility of directors
-
IR
2022/06/18
Notice of resolutions at 76th Ordinary General Shareholders’ Meeting
-
IR
2022/06/10
Notice regarding acquisition of Treasury Stock
-
IR
2022/06/06
Notice Regarding Taiyo Holdings Co., Ltd.’s View of Dissenting Recommendation by Proxy Advisory Company ISS
-
IR
2022/05/26
NOTICE OF 76TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
-
IR
2022/05/25
NOTICE REGARDING COMPANY’S PROPOSITIONS FOR 76TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
-
IR
2022/05/12
Notice regarding Candidate for Chairman of the Board of Directors
-
IR
2022/05/12
Notice regarding changes in representative directors (Additional Appointment) and responsibility of directors
-
IR
2022/05/10
Notice regarding acquisition of Treasury Stock
-
IR
2022/04/28
Notice regarding organizational changes and personnel changes
-
IR
2022/04/28
Notice regarding changes in responsibility of directors
-
IR
2022/04/28
Notice regarding Director and Audit & Supervisory Board Member candidates
-
IR
2022/04/28
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2022)
-
IR
2022/04/28
Notice regarding dividends from surplus
-
IR
2022/04/28
Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
-
IR
2022/04/08
Notice regarding acquisition of Treasury Stock
-
IR
2022/03/18
Notice regarding organizational changes and personnel changes
-
IR
2022/03/18
Notice regarding acquisition plan of Treasury Stock
-
IR
2022/03/16
Integrated Report 2021
-
IR
2022/02/25
Notice regarding acquisition of approval to add indications, etc. for “Kytril® injections and intravenous infusion bags” that act as 5-HT3 receptor antagonists
-
IR
2022/02/14
Notice regarding acquisition and acquisition completion of Treasury Stock
-
IR
2022/02/10
Notice regarding acquisition of Treasury Stock
-
IR
2022/02/08
Consolidated Financial Result Digest FY2022 Q3 (Fiscal Year Ending March 31, 2022)
-
IR
2022/02/08
Notice of revised forecasts for the full year of FY2022
-
IR
2022/02/08
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022
-
IR
2022/01/07
Notice regarding acquisition of Treasury Stock
-
IR
2021/12/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/12/02
Notice of Completion regarding Succession of Manufacturing and Marketing Approval for Four Long Listed Products
-
IR
2021/11/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/11/05
Consolidated Financial Result Digest FY2022 Q2 (Fiscal Year Ending March 31, 2022)
-
IR
2021/11/05
Notice of revised forecasts for the full year of FY2022
-
IR
2021/11/05
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2022
-
IR
2021/10/08
Notice regarding acquisition of Treasury Stock
-
IR
2021/10/01
Annual Securities Report for the 75th business term (April 1, 2020, to March 31, 2021)
-
IR
2021/09/17
Notice Regarding an Application to Select the New Market Segment, Prime Market
-
IR
2021/09/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/08/12
Notice Regarding Compliance with Listing Maintenance Criteria for New Market Segment “Prime Market”
-
IR
2021/08/12
Notice regarding completion of payment for issuance of additional shares of stock to provide for stock compensation system (comprising transfer-restricted stock compensation and performance-linked stock compensation)
-
IR
2021/08/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/08/04
Notice regarding issuance of additional shares of stock to provide for stock compensation system (comprising transfer-restricted stock compensation and performance-linked stock compensation)
-
IR
2021/08/02
Consolidated Financial Result Digest FY2022 Q1
-
IR
2021/08/02
Notice Regarding Stock Split, Associated Partial Amendment to the Articles of Incorporation, Revision to Dividend Forecasts and Others
-
IR
2021/08/02
Notice of Revised Forecasts for the second quarter of FY2022 and for the full year of FY2022
-
IR
2021/08/02
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2022
-
IR
2021/07/09
Notice regarding acquisition of Treasury Stock
-
IR
2021/06/28
Matters Concerning Controlling Shareholders, Etc.
-
IR
2021/06/28
Position and Policy Concerning Lowering of Trading Unit
-
IR
2021/06/10
Briefing Material on the Long-Term Management Plan held on Monday, June 7, 2021
-
IR
2021/06/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/06/04
Notice Regarding Formulation of Long-Term Management Plan
-
IR
2021/05/27
NOTICE OF 75TH ORDINARY GENERAL SHAREHOLDERS’ MEETING
-
IR
2021/05/12
Notice of Partial Correction to “Consolidated Financial Result Digest FY2021 Q4 (Fiscal Year Ending March 31, 2021)”
-
IR
2021/05/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/04/30
Notice regarding revision of dividend forecast for the fiscal year ending March 2021 (including Commemorative Dividend on 20th anniversary of listing)
-
IR
2021/04/30
Consolidated Financial Result Digest FY2021 Q4 (Fiscal Year Ending March 31, 2021)
-
IR
2021/04/30
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
-
IR
2021/04/16
Notice regarding acquisition of a distribution center by our Consolidated Subsidiary
-
IR
2021/03/29
Notice regarding organizational changes and personnel changes
-
IR
2021/03/29
Notice regarding personnel changes
-
IR
2021/03/23
Notice regarding acquisition and acquisition completion of Treasury Stock
-
IR
2021/03/22
Notice regarding acquisition of Treasury Stock
-
IR
2021/03/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/02/10
Notice regarding acquisition of Treasury Stock
-
IR
2021/02/05
Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021
-
IR
2021/02/05
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2021
-
IR
2021/02/05
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2021
-
IR
2021/01/08
Notice regarding acquisition of Treasury Stock
